Consumers should not purchase or use Linsen Double Caulis Plus, a dietary supplement advertised for joint, gout, and back pain on various websites including www.tranpharma.com, and possibly sold in some retail stores, because it contains hidden drugs that can cause serious health problems, the Food and Drug Administration (FDA) warned in a Public Notification.
An FDA laboratory analysis confirmed Linsen Double Caulis Plus contains dexamethasone, a corticosteroid commonly used to treat inflammatory conditions. Use of corticosteroids can impair a person’s ability to fight infections and cause high blood sugar levels, muscle injuries and psychiatric problems. Long-term or high-dose use of corticosteroids can suppress the adrenal gland. Abrupt discontinuation can lead to withdrawal symptoms.
The undeclared drug in Linsen Double Caulis Plus can also interact with other medications people may be taking and cause serious side effects, the FDA warned.
Anyone who is or has taken Linsen Double Caulis Plus should immediately consult with their health care professional in order to safely discontinue use of this supplement, and to assess the risk of withdrawal from corticosteroids. “Only licensed health care professionals can evaluate patients for the risk or existence of adrenal suppression,” the FDA said in the Public Notification. To date, the FDA has not received any reports of adverse events in patients who have taken this supplement.
Anyone who has used this supplement and experienced side effects or adverse events should file a report with the FDA MedWatch Adverse Event Reporting Program at www.FDA.gov/MedWatch/Report.htm.
Source: FDA Public Notification